Abstract
Glioma is a highly malignant type of intracranial tumor with a poor prognosis resulting from traditional chemo-resistance with temozolomide (TMZ). Luteolin has been detected to exert limited anti-tumor effects on gliomas, while valproic acid (VPA) is a common chemotherapy sensitizer in the treatment of tumors. In this study, three glioma cell lines including U251, LN229 and SNB19 were selected for evaluation of combined anti-tumor effects of VPA and luteolin via Cell Counting Kit-8 (CCK-8) assay, colony formation assay, wound-healing assay, flow cytometry and western blot assay. The results disclosed that VPA sensitized glioma cells to luteolin by repressing cell viability, colony formation and migration. Mechanically, VPA boosted cellular apoptosis and cell-cycle arrest by increased level of cleaved caspase-3/caspase-3, cleaved PARP/PARP and Bax/Bcl-2. In addition, VPA also facilitated cellular autophagy via the decline of p62, p-Akt/Akt and the accumulation of LC3-II. These findings suggested that VPA enhanced the anticancer effects of luteolin by strengthening apoptosis and autophagy via Akt signaling, which could be adopted as a novel therapy for glioma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmed S, Khan H, Fratantonio D, Hasan MM, Sharifi S, Fathi N, Ullah H, Rastrelli L (2019) Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives. Phytomedicine 59:152883. https://doi.org/10.1016/j.phymed.2019.152883
Anson DM, Wilcox RM, Huseman ED, Stump TA, Paris RL, Darkwah BO, Lin S, Adegoke AO, Gryka RJ, Jean-Louis DS, Amos S (2018) Luteolin Decreases Epidermal Growth Factor Receptor-Mediated Cell Proliferation and Induces Apoptosis in Glioblastoma Cell Lines. Basic Clin Pharmacol Toxicol 123(6):678–686. https://doi.org/10.1111/bcpt.13077
Booth LA, Roberts JL, Dent P (2019) The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib. Semin Cancer Biol. https://doi.org/10.1016/j.semcancer.2019.10.013
Cao Q, Shi Y, Wang X, Yang J, Mi Y, Zhai G, Zhang M (2019) Circular METRN RNA hsa_circ_0037251 Promotes Glioma Progression by Sponging miR-1229-3p and Regulating mTOR Expression. Sci Rep 9(1):19791. https://doi.org/10.1038/s41598-019-56417-8
Chen JH, Zheng YL, Xu CQ, Gu LZ, Ding ZL, Qin L, Wang Y, Fu R, Wan YF, Hu CP (2017) Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1. Biol Chem 398(7):785–792. https://doi.org/10.1515/hsz-2016-0307
Curti V, Di Lorenzo A, Dacrema M, Xiao J, Nabavi SM, Daglia M (2017) In vitro polyphenol effects on apoptosis: An update of literature data. Semin Cancer Biol 46:119–131. https://doi.org/10.1016/j.semcancer.2017.08.005
Eckert M, Klumpp L, Huber SM (2017) Cellular effects of the antiepileptic drug valproic acid in glioblastoma. Cell Physiol 44(4):1591–1605. https://doi.org/10.1159/000485753
El Gueder D, Maatouk M, Kalboussi Z, Daouefi Z, Chaaban H, Ioannou I, Ghedira K, Ghedira LC, Luis J (2018) Heat processing effect of luteolin on anti-metastasis activity of human glioblastoma cells U87. Environ Sci Pollut Res Int 25(36):36545–36554. https://doi.org/10.1007/s11356-018-3477-x
Emdad L, Bhoopathi P, Talukdar S, Pradhan AK, Sarkar D, Wang XY, Das SK, Fisher PB (2019) Recent insights into apoptosis and toxic autophagy: the roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic. Semin Cancer Biol. https://doi.org/10.1016/j.semcancer.2019.07.013
Gao G, Ge R, Li Y, Liu S (2019) Luteolin exhibits anti-breast cancer property through up-regulating miR-203. Artif Cells Nanomed Biotechnol 47(1):3265–3271. https://doi.org/10.1080/21691401.2019.1646749
Garcia CG, Kahn SA, Geraldo LHM, Romano I, Domith I, Silva D, Dos Santos AF, Ferreira MJ, Portugal CC, de Souza JM, Romao LF, Netto ADP, Lima FRS, Cossenza M (2018) Combination therapy with sulfasalazine and valproic acid promotes human glioblastoma cell death through imbalance of the intracellular oxidative response. Mol Neurobiol 55(8):6816–6833. https://doi.org/10.1007/s12035-018-0895-1
Geng F, Lu GF, Ji MH, Kong DY, Wang SY, Tian H, Xie ZM, Pan M, Gong NL (2019) MicroRNA-26b-3p/ANTXR1 signaling modulates proliferation, migration, and apoptosis of glioma. Am J Transl Res 11(12):7568–7578
Huang L, Jin K, Lan H (2019) Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase. Oncol Lett 17(4):3842–3850. https://doi.org/10.3892/ol.2019.10052
Iida K, Naiki T, Naiki-Ito A, Suzuki S, Kato H, Nozaki S, Nagai T, Etani T, Nagayasu Y, Ando R, Kawai N, Yasui T, Takahashi S (2020) Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway. Cancer Sci. https://doi.org/10.1111/cas.14334
Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, Imran A, Orhan IE, Rizwan M, Atif M, Gondal TA, Mubarak MS (2019) Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother 112:108612. https://doi.org/10.1016/j.biopha.2019.108612
Kiweler N, Wunsch D, Wirth M, Mahendrarajah N, Schneider G, Stauber RH, Brenner W, Butter F, Kramer OH (2020) Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes. J Cancer Res Clin Oncol 146(2):343–356. https://doi.org/10.1007/s00432-019-03118-4
Lee JE, Kim JH (2015) Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1. Genet Mol Biol 38(4):527–533. https://doi.org/10.1590/S1415-475738420150028
Li H, Zhang Z, Gao C, Wu S, Duan Q, Wu H, Wang C, Shen Q, Yin T (2019) Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells. Cell Biosci 9:50. https://doi.org/10.1186/s13578-019-0312-0
Li Z, Zhang Y, Chen L, Li H (2018) The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2. Food Func 9(5):3018–3027. https://doi.org/10.1039/c8fo00033f
Lin T, Ren Q, Zuo W, Jia R, Xie L, Lin R, Zhao H, Chen J, Lei Y, Wang P, Dong H, Huang L, Cai J, Peng Y, Yu Z, Tan J, Wang S (2019) Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs. J Exp Clin Cancer Res CR 38(1):150. https://doi.org/10.1186/s13046-019-1160-9
Naiki-Ito A, Naiki T, Kato H, Iida K, Etani T, Nagayasu Y, Suzuki S, Yamashita Y, Inaguma S, Onishi M, Tanaka Y, Yasui T, Takahashi S (2019) Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer. Carcinogenesis. https://doi.org/10.1093/carcin/bgz193
Qin L, Wang Z, Tao L, Wang Y (2010) ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy. Autophagy 6(2):239–247. https://doi.org/10.4161/auto.6.2.11062
Riva G, Cilibrasi C, Bazzoni R, Cadamuro M, Negroni C, Butta V, Strazzabosco M, Dalpra L, Lavitrano M, Bentivegna A (2018) Valproic acid inhibits proliferation and reduces invasiveness in glioma stem cells through Wnt/beta catenin signalling activation. Genes. https://doi.org/10.3390/genes9110522
Ryu CH, Yoon WS, Park KY, Kim SM, Lim JY, Woo JS, Jeong CH, Hou Y, Jeun SS (2012) Valproic acid downregulates the expression of MGMT and sensitizes temozolomide-resistant glioma cells. J Biomed Biotechnol 2012:987495. https://doi.org/10.1155/2012/987495
Sargazi S, Kooshkaki O, Zavar Reza J, Saravani R, Zarei Jaliani H, Mirinejad S, Meshkini F (2019) Mild antagonistic effect of Valproic acid in combination with AZD2461 in MCF-7 breast cancer cells. Med J Islamic Repub Iran 33:29. https://doi.org/10.34171/mjiri.33.29
Shao N, Mao J, Xue L, Wang R, Zhi F, Lan Q (2019) Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma. J Neurooncol 141(2):277–288. https://doi.org/10.1007/s11060-018-03043-5
Shirjang S, Mansoori B, Asghari S, Duijf PHG, Mohammadi A, Gjerstorff M, Baradaran B (2019) MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis. Free Radical Biol Med 139:1–15. https://doi.org/10.1016/j.freeradbiomed.2019.05.017
Song CY, Guo JF, Liu Y, Tang BS (2012) Autophagy and its comprehensive impact on ALS. Int J Neurosci 122(12):695–703. https://doi.org/10.3109/00207454.2012.714430
Sun J, Piao J, Li N, Yang Y, Kim KY, Lin Z (2020) Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer. FEBS J 287(10):2118–2133. https://doi.org/10.1111/febs.15122
Tseng JH, Chen CY, Chen PC, Hsiao SH, Fan CC, Liang YC, Chen CP (2017) Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression. Oncotarget 8(9):14666–14679. https://doi.org/10.18632/oncotarget.14716
Ustun S, Hafren A, Hofius D (2017) Autophagy as a mediator of life and death in plants. Curr Opin Plant Biol 40:122–130. https://doi.org/10.1016/j.pbi.2017.08.011
Valentin R, Grabow S, Davids MS (2018) The rise of apoptosis: targeting apoptosis in hematologic malignancies. Blood 132(12):1248–1264. https://doi.org/10.1182/blood-2018-02-791350
Wang P, Shao BZ, Deng Z, Chen S, Yue Z, Miao CY (2018) Autophagy in ischemic stroke. Prog Neurobiol 163–164:98–117. https://doi.org/10.1016/j.pneurobio.2018.01.001
Wu C, Xu Q, Chen X, Liu J (2019) Delivery luteolin with folacin-modified nanoparticle for glioma therapy. Int J Nanomed 14:7515–7531. https://doi.org/10.2147/IJN.S214585
Wu L, Feng H, Hu J, Tian X, Zhang C (2016) Valproic acid (VPA) promotes the epithelial mesenchymal transition of hepatocarcinoma cells via transcriptional and post-transcriptional up regulation of Snail. Biomed Pharmacother 84:1029–1035. https://doi.org/10.1016/j.biopha.2016.10.023
Xiong Z, Zhou C, Wang L, Zhu R, Zhong L, Wan D, Wang Q (2019) Circular RNA SMO sponges miR-338-3p to promote the growth of glioma by enhancing the expression of SMO. Aging (Albany NY) 11(24):12345–12360. https://doi.org/10.18632/aging.102576
Xu X, Wang Z, Liu N, Cheng Y, Jin W, Zhang P, Wang X, Yang H, Liu H, Zhang Y, Tu Y (2018) Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ. Int J Oncol 53(1):189–202. https://doi.org/10.3892/ijo.2018.4382
Xu Y, Xu D, Zhu SJ, Ye B, Dong JD, Zhang YL, Zhang Y (2015) Induction of apoptosis and autophagy in metastatic thyroid cancer cells by valproic acid (VPA). Int J Clin Exp Pathol 8(7):8291–8297
Yao Y, Rao C, Zheng G, Wang S (2019) Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR384/pleiotrophin axis. Oncol Rep 42(1):131–141. https://doi.org/10.3892/or.2019.7136
Yi GZ, Liu YW, Xiang W, Wang H, Chen ZY, Xie SD, Qi ST (2016) Akt and beta-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line. J Neurol Sci 367:101–106. https://doi.org/10.1016/j.jns.2016.05.054
You Y, Wang R, Shao N, Zhi F, Yang Y (2019) Luteolin suppresses tumor proliferation through inducing apoptosis and autophagy via MAPK activation in glioma. Onco Targets Ther 12:2383–2396. https://doi.org/10.2147/OTT.S191158
Yu Q, Zhang M, Ying Q, Xie X, Yue S, Tong B, Wei Q, Bai Z, Ma L (2019) Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment. Cell Death Dis 10(3):218. https://doi.org/10.1038/s41419-019-1447-y
Zhang C, Liu S, Yuan X, Hu Z, Li H, Wu M, Yuan J, Zhao Z, Su J, Wang X, Liao Y, Liu Q (2016) Valproic acid promotes human glioma U87 cells apoptosis and inhibits glycogen synthase kinase-3beta through ERK/Akt signaling. Cell Physiol Biochem 39(6):2173–2185. https://doi.org/10.1159/000447912
Zheng S, Cheng Y, Teng Y, Liu X, Yu T, Wang Y, Liu J, Hu Y, Wu C, Wang X, Liu Y, You C, Gao X, Wei Y (2017) Application of luteolin nanomicelles anti-glioma effect with improvement in vitro and in vivo. Oncotarget 8(37):61146–61162. https://doi.org/10.18632/oncotarget.18019
Funding
No financial support.
Author information
Authors and Affiliations
Contributions
HW, YF and WR are responsible for the conceptualization and design of the studies. HW and WR performed all experiments and analyzed the data. HW and YF wrote the manuscript. GW and ZF reviewed and finalized the final draft.
Corresponding authors
Ethics declarations
Conflict of interest:
All the authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Han, W., Yu, F., Wang, R. et al. Valproic Acid Sensitizes Glioma Cells to Luteolin Through Induction of Apoptosis and Autophagy via Akt Signaling. Cell Mol Neurobiol 41, 1625–1634 (2021). https://doi.org/10.1007/s10571-020-00930-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-020-00930-2